Badreddin Edris - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Badreddin Edris

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The Journal of Pathology|February 2, 2012

ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumourBadreddin Edris, Iñigo Espinosa, Thomas Mühlenberg, et al.

Genome Biology|August 30, 2012

Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancersAlayne L Brunner, Andrew H Beck, Badreddin Edris, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsStephen B Willingham, Jens-Peter Volkmer, Andrew J Gentles, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The Journal of Pathology|February 2, 2012

ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumourBadreddin Edris, Iñigo Espinosa, Thomas Mühlenberg, et al.

Genome Biology|August 30, 2012

Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancersAlayne L Brunner, Andrew H Beck, Badreddin Edris, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsStephen B Willingham, Jens-Peter Volkmer, Andrew J Gentles, et al.

Pageof 2